APA (7th ed.) Citation

T, C., G, M. O., C, S., G, S. M., IJ, T., V, L. G., . . . S, M. (2024). Cyclosporine A in hospitalized COVID-19 pneumonia patients to prevent the development of interstitial lung disease: A pilot randomized clinical trial. Scientific reports, 14(1), 3789. https://doi.org/10.1038/s41598-024-54196-5

Chicago Style (17th ed.) Citation

T, Cobo-Ibáñez, et al. "Cyclosporine A in Hospitalized COVID-19 Pneumonia Patients to Prevent the Development of Interstitial Lung Disease: A Pilot Randomized Clinical Trial." Scientific Reports 14, no. 1 (2024): 3789. https://doi.org/10.1038/s41598-024-54196-5.

MLA (9th ed.) Citation

T, Cobo-Ibáñez, et al. "Cyclosporine A in Hospitalized COVID-19 Pneumonia Patients to Prevent the Development of Interstitial Lung Disease: A Pilot Randomized Clinical Trial." Scientific Reports, vol. 14, no. 1, 2024, p. 3789, https://doi.org/10.1038/s41598-024-54196-5.